Compare SGHC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHC | STVN |
|---|---|---|
| Founded | 2020 | 1949 |
| Country | Guernsey | Italy |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.2B |
| IPO Year | 2021 | 2021 |
| Metric | SGHC | STVN |
|---|---|---|
| Price | $10.67 | $15.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $17.33 | ★ $25.67 |
| AVG Volume (30 Days) | ★ 2.4M | 524.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.85% | 0.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.10 | $10.26 |
| Revenue Next Year | $14.20 | $10.02 |
| P/E Ratio | ★ $20.80 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.59 | $13.91 |
| 52 Week High | $14.38 | $28.00 |
| Indicator | SGHC | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 53.54 | 47.06 |
| Support Level | $10.59 | $14.03 |
| Resistance Level | $11.60 | $17.14 |
| Average True Range (ATR) | 0.47 | 0.83 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 37.93 | 38.17 |
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.